Literature DB >> 10201660

Is ropivacaine less potent than bupivacaine?

R D'Angelo, R L James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10201660     DOI： 10.1097/00000542-199904000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

Review 1.  Anaesthetic agents for advanced regional anaesthesia: a North American perspective.

Authors:  Chester C Buckenmaier; Lisa L Bleckner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Comparison of Epidural Bupivacaine, Levobupivacaine and Dexmedetomidine in Patients Undergoing Vascular Surgery.

Authors:  Lakshmi Adalagere Sathyanarayana; Vijayakumar M Heggeri; Parimala Prasanna Simha; Satish Narasimaiah; Manjunath Narasimaiah; Bharathi Katheraguppa Subbarao
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 4.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Ultrasound-guided regional anesthesia for procedures of the upper extremity.

Authors:  Farheen Mirza; Anthony R Brown
Journal:  Anesthesiol Res Pract       Date:  2011-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.